These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10999355)

  • 1. Evaluation of intect test strips for detecting adulteration of urine specimens used for drugs-of-abuse testing.
    King EJ
    J Anal Toxicol; 2000 Sep; 24(6):456. PubMed ID: 10999355
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of spot tests with AdultaCheck 6 and Intect 7 urine test strips for detecting the presence of adulterants in urine specimens.
    Dasgupta A; Chughtai O; Hannah C; Davis B; Wells A
    Clin Chim Acta; 2004 Oct; 348(1-2):19-25. PubMed ID: 15369731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of AdultaCheck 4 test strips for the detection of adulteration at the point of collection of urine specimens used for drugs-of-abuse testing.
    King EJ
    J Anal Toxicol; 1999; 23(1):72. PubMed ID: 10022215
    [No Abstract]   [Full Text] [Related]  

  • 4. Performance evaluation of three on-site adulterant detection devices for urine specimens.
    Peace MR; Tarnai LD
    J Anal Toxicol; 2002 Oct; 26(7):464-70. PubMed ID: 12423001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results.
    Cone EJ; Lange R; Darwin WD
    J Anal Toxicol; 1998 Oct; 22(6):460-73. PubMed ID: 9788521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papain: a novel urine adulterant.
    Burrows DL; Nicolaides A; Rice PJ; Dufforc M; Johnson DA; Ferslew KE
    J Anal Toxicol; 2005; 29(5):275-95. PubMed ID: 16105251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False-negative results in the immunoassay analysis of drugs of abuse: can adulterants be detected by sample check test?
    Matriciani B; Huppertz B; Keller R; Weiskirchen R
    Ann Clin Biochem; 2018 May; 55(3):348-354. PubMed ID: 28728424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine drug-testing tampering approaches: Turkish probationers.
    Aydoğdu M; Akgür SA
    Med Sci Law; 2021 Jan; 61(1):6-13. PubMed ID: 32924786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators.
    Fraser AD; Zamecnik J
    Ther Drug Monit; 2003 Dec; 25(6):723-7. PubMed ID: 14639059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adulteration of urine drug testing--an exaggerated cause of concern].
    Beck O; Bohlin M; Bragd F; Bragd J; Greitz O
    Lakartidningen; 2000 Feb; 97(7):703-6. PubMed ID: 10740378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adulterants in Urine Drug Testing.
    Fu S
    Adv Clin Chem; 2016; 76():123-63. PubMed ID: 27645818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of urine adulterants on commercial drug abuse screening test strip results.
    Rajšić I; Javorac D; Tatović S; Repić A; Đukić-Ćosić D; Đorđević S; Lukić V; Bulat Z
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):87-93. PubMed ID: 32597134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel spot tests for detecting the presence of zinc sulfate in urine, a newly introduced urinary adulterant to invalidate drugs of abuse testing.
    Welsh KJ; Dierksen JE; Actor JK; Dasgupta A
    Am J Clin Pathol; 2013 Oct; 140(4):572-8. PubMed ID: 24045556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicological screening for drugs of abuse in samples adulterated with household chemicals.
    Uebel RA; Wium CA
    S Afr Med J; 2002 Jul; 92(7):547-9. PubMed ID: 12197198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the effects of adulterants on drug detection via enzyme-linked immunosorbent assay and adulterant tests strips.
    Olivieri B; Marić M; Bridge C
    Drug Test Anal; 2018 Sep; 10(9):1383-1393. PubMed ID: 29749024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating new marijuana use from residual drug excretion in occasional marijuana users.
    Huestis MA; Cone EJ
    J Anal Toxicol; 1998 Oct; 22(6):445-54. PubMed ID: 9788519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of adulterants on urine screen for drugs of abuse: detection by an on-site dipstick device.
    Wong R
    Am Clin Lab; 2002; 21(1):37-9. PubMed ID: 11975450
    [No Abstract]   [Full Text] [Related]  

  • 18. An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening.
    George S; Braithwaite RA
    Addiction; 1995 Jul; 90(7):967-70. PubMed ID: 7663318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of creatinine analyses of urine when screening for abused drugs.
    Lafolie P; Beck O; Blennow G; Boréus L; Borg S; Elwin CE; Karlsson L; Odelius G; Hjemdahl P
    Clin Chem; 1991 Nov; 37(11):1927-31. PubMed ID: 1934467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of freezing point depression osmolality for classifying random urine specimens defined as substituted under HHS/DOT criteria.
    Cook JD; Hannon MW; Vo T; Caplan YH
    J Anal Toxicol; 2002 Oct; 26(7):424-9. PubMed ID: 12422996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.